Common Contracts
4 similar Settlement Agreement contracts
SETTLEMENT AGREEMENTSettlement Agreement • March 7th, 2022
This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”) (collectively, the “United States”), Mallinckrodt plc and Mallinckrodt ARD LLC (f/k/a Questcor Pharmaceuticals, Inc.), debtors and debtors-in-possession acting on behalf of themselves and their estates (collectively, “Mallinckrodt”)1, and James Landolt (“Relator”) (hereafter collectively referred to as “the Parties”), through their authorized representatives.
SETTLEMENT AGREEMENTSettlement Agreement • March 4th, 2022
This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”) (collectively, the “United States”), Mallinckrodt plc and Mallinckrodt ARD LLC (f/k/a Questcor Pharmaceuticals, Inc.), debtors and debtors-in-possession acting on behalf of themselves and their estates (collectively, “Mallinckrodt”)1, and James Landolt (“Relator”) (hereafter collectively referred to as “the Parties”), through their authorized representatives.
SETTLEMENT AGREEMENTSettlement Agreement • March 4th, 2022
This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”) (collectively, the “United States”), Mallinckrodt plc and Mallinckrodt ARD LLC (f/k/a Questcor Pharmaceuticals, Inc.), debtors and debtors-in-possession acting on behalf of themselves and their estates (collectively, “Mallinckrodt”)1, and James Landolt (“Relator”) (hereafter collectively referred to as “the Parties”), through their authorized representatives.
SETTLEMENT AGREEMENTSettlement Agreement • March 4th, 2022
This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”) (collectively, the “United States”), Mallinckrodt plc and Mallinckrodt ARD LLC (f/k/a Questcor Pharmaceuticals, Inc.), debtors and debtors-in-possession acting on behalf of themselves and their estates (collectively, “Mallinckrodt”)1, and Charles Strunck, Lisa Pratta, and Scott Clark (each a “Relator” and, collectively, the “Relators”) (hereafter collectively referred to as “the Parties”), through their authorized representatives.
